Jamie Flerlage

Division Chief Pediatric Hematology/Oncology

University of Rochester Medical Center

United States

Research Interests

Explore related searches

Professors in United States

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Jamie Flerlage is the Division Chief of Pediatric Hematology/Oncology at the University of Rochester Medical Center, USA. His research primarily focuses on Hodgkin lymphoma, including treatment strategies, prognostic factors, and the experiences of patients and caregivers. Recent publications address distinct cell state ecosystems in nodular lymphocyte-predominant Hodgkin lymphoma and emphasize the importance of collaborative international studies in advancing treatment outcomes.

Articles (10)

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Collaborators (6)

Chan Yoon Cheah

University of Western Australia

AUSTRALIA

View details

Christine Smith

Assistant Professor of Clinical Pediatrics

Vanderbilt University Medical Center

UNITED STATES

View details

Hollie Lai

Clinical Professor (Volunteer)

University of California Irvine Medical Center

UNITED STATES

View details

Eliza Hawkes

Associate Professor

MONASH UNIVERSITY

AUSTRALIA

View details

Lena Specht

Professor of Oncology

University of Copenhagen

DENMARK

View details

Ajay Major

Assistant Professor of Medicine

University of Colorado School of Medicine

UNITED STATES

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Jamie Flerlage

Research Interests

Explore related searches

Contact this professor

About

Articles (10)

Distinct cell state ecosystems for nodular lymphocyte-predominant Hodgkin lymphoma

Patient and care partner perspectives on treatment decision-making in nodular lymphocyte-predominant Hodgkin lymphoma (NLPHL): a Global nLPHL One Working Group (GLOW) study

Curative Treatment of Pediatric Hodgkin Lymphoma With Doxorubicin, Bleomycin, Vinblastine, and Dacarbazine and Consolidation Radiotherapy: A Systematic Review and Suggested Recommendations

Global nLPHL One Working Group (GLOW) Research Roadmap for Nodular Lymphocyte‐Predominant Hodgkin Lymphoma

CT, MRI, and FDG PET/CT in the Assessment of Lymph Node Involvement in Pediatric Hodgkin Lymphoma: An Expert Consensus Definition by an International Collaboration on Staging Evaluation and Response Criteria Harmonization for Children, Adolescent, and Young Adult Hodgkin Lymphoma (SEARCH for CAYAHL)

International Prognostic Score for Nodular Lymphocyte-Predominant Hodgkin Lymphoma

Hodgkin lymphoma involving the extra-axial CNS: an AHOD1331, PHL-C1, and PHL-C2 report from the COG and EuroNet-PHL

Systemic Biological Mechanisms of Neurocognitive Dysfunction in Long-Term Survivors of Childhood Hodgkin Lymphoma

Disease site number was not prognostic in a low-risk Hodgkin lymphoma combined modality trial: revisiting PHC HOD90

Significance of E-lesions in Hodgkin lymphoma and the creation of a new consensus definition: a report from SEARCH

Collaborators (6)

Chan Yoon Cheah

Christine Smith

Hollie Lai

Eliza Hawkes

Lena Specht

Ajay Major

Make your next move.